K.J. Harrison & Partners’s CVS Health CVS Stock Holding History

K.J. Harrison & Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,221	Closed	-$769K	–	202
2024 Q3	$769K	Sell	13,221 -20,000	-60%	-$1.17M	0.12%	153
2024 Q2	$1.96M	Hold	33,221	–	–	0.32%	80
2024 Q1	$2.65M	Sell	33,221 -20,000	-38%	-$1.53M	0.41%	70
2023 Q4	$4.2M	Buy	53,221 +19,800	+59%	+$1.41M	0.71%	43
2023 Q3	$2.33M	Sell	33,421 -7,000	-17%	-$496K	0.53%	62
2023 Q2	$2.78M	Buy	40,421 +14,200	+54%	+$1.01M	0.51%	64
2023 Q1	$1.89M	Buy	26,221 +1,000	+4%	+$83.9K	0.38%	81
2022 Q4	$3.18M	Sell	25,221 -8,014	-24%	-$773K	0.62%	54
2022 Q3	$3.25M	Buy	33,235 +8,014	+32%	+$793K	1.15%	17
2022 Q2	$2.34M	Sell	25,221 -800	-3%	-$78.1K	0.63%	49
2022 Q1	$2.63M	Sell	26,021 -5,954	-19%	-$625K	0.42%	71
2021 Q4	$3.3M	Buy	31,975 +388	+1%	+$35.9K	0.47%	62
2021 Q3	$2.7M	Sell	31,587 -6,488	-17%	-$543K	0.39%	79
2021 Q2	$3.18K	Sell	38,075 -12,000	-24%	-$983K	0.33%	66
2021 Q1	$3.77M	Hold	50,075	–	–	0.58%	44
2020 Q4	$3.42M	Buy	50,075 +10,800	+27%	+$702K	0.56%	54
2020 Q3	$2.3M	Hold	39,275	–	–	0.47%	74
2020 Q2	$2.55M	Sell	39,275 -3,400	-8%	-$214K	0.7%	47
2020 Q1	$2.53M	Buy	42,675 +5,000	+13%	+$334K	1.41%	22
2019 Q4	$2.8M	Sell	37,675 -1,383	-4%	-$97.1K	0.7%	54
2019 Q3	$2.46M	Sell	39,058 -5,900	-13%	-$350K	0.68%	45
2019 Q2	$2.45M	Buy	44,958 +6,000	+15%	+$323K	0.78%	42
2019 Q1	$2.1M	Buy	38,958 +8,200	+27%	+$506K	0.73%	49
2018 Q4	$2.02M	Buy	30,758 +11,983	+64%	+$894K	1.23%	25
2018 Q3	$1.48M	Buy	18,775 +10,967	+140%	+$784K	0.38%	93
2018 Q2	$502K	Buy	7,808 +2,333	+43%	+$154K	0.14%	140
2018 Q1	$341K	Buy	+5,475	New	+$393K	0.11%	138
2017 Q4	–	Sell	-48,255	Closed	-$3.92M	–	177
2017 Q3	$3.92M	Sell	48,255 -12,000	-20%	-$949K	1.35%	23
2017 Q2	$4.85M	Buy	60,255 +5,964	+11%	+$471K	1.9%	8
2017 Q1	$4.26M	Sell	54,291 -14,839	-21%	-$1.18M	1.74%	12
2016 Q4	$5.46M	Buy	69,130 +31,510	+84%	+$2.55M	2.18%	4
2016 Q3	$3.35M	Buy	37,620 +6,395	+20%	+$604K	1.59%	10
2016 Q2	$2.99M	Sell	31,225 -200	-0.6%	-$19.9K	1.6%	12
2016 Q1	$3.26M	Buy	31,425 +12,250	+64%	+$1.19M	1.74%	11
2015 Q4	$1.88M	Hold	19,175	–	–	0.82%	43
2015 Q3	$1.85M	Hold	19,175	–	–	0.91%	37
2015 Q2	$2.01M	Sell	19,175 -1,000	-5%	-$102K	0.6%	52
2015 Q1	$2.08M	Hold	20,175	–	–	0.61%	54
2014 Q4	$1.94M	Hold	20,175	–	–	0.56%	54
2014 Q3	$1.61M	Sell	20,175 -125	-0.6%	-$9.85K	0.45%	68
2014 Q2	$1.53M	Buy	20,300 +600	+3%	+$45.3K	0.44%	70
2014 Q1	$1.47M	Hold	19,700	–	–	0.44%	72
2013 Q4	$1.5M	Hold	19,700	–	–	0.44%	70
2013 Q3	$1.12M	Sell	19,700 -600	-3%	-$35.8K	0.41%	72
2013 Q2	$1.16M	Buy	+20,300	New	+$1.18M	0.47%	61

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

K.J. Harrison & Partners's CVS Position: Q4 2024 in Review

K.J. Harrison & Partners sold out of CVS Health (CVS) in Q4 2024, closing a stake of 13,221 shares — an estimated $769K sold.

K.J. Harrison & Partners first reported a position in CVS in Q2 2013 and held it in 45 quarters. The position peaked at $5.46M in Q4 2016. 1,669 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

K.J. Harrison & Partners reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
K.J. Harrison & Partners sold 13,221 CVS Health shares in Q4 2024, an estimated $769K.
K.J. Harrison & Partners first reported a position in CVS Health in Q2 2013 and held it in 45 quarters.
K.J. Harrison & Partners's CVS Health position peaked at $5.46M in Q4 2016.
1,669 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on K.J. Harrison & Partners's 13F filing for Q4 2024, filed 5 Feb 2025.